Home
Science & Technology
Publications

Publications:
Our Research

Filter

Filter

Research Area
Technology
Resource type
Category
230 results found
May 5, 2021
Publication
Novavax led
Pre-print
COVID-19, Seasonal influenza
Combination Respiratory Vaccine Containing Recombinant SARS-CoV-2 Spike and Quadrivalent Seasonal Influenza Hemagglutinin Nanoparticles with Matrix-M Adjuvant
Massare, Michael J., Patel, Nita, Zhou, Bin, et al.
View
May 5, 2021
Publication
Novavax led
New England Journal of Medicine
COVID-19
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
Shinde, Vivek, Bhikha, Sutika, Hoosain, Zaheer, et al.
View
May 4, 2021
Clinical trial protocol
COVID-19
Current Protocol for Phase 3 Clinical Trial of NVX-CoV2373 in the U.K.
View/Download
May 4, 2021
Presentation
COVID-19
Novavax COVID-19 Program Update for World Vaccine Congress

Dr. Gregory Glenn's presentation at the World Vaccine Congress Washington 2021.

Glenn, Gregory
View/Download
Apr 14, 2021
Publication
Novavax included/third party collaborative
Cell Host and Microbe
COVID-19
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
Shen, Xiaoying, Tang, Haili, McDanal, Charlene, et al.
View
Apr 13, 2021
Publication
Collaborative
Annals of Internal Medicine
COVID-19, Matrix-M® adjuvant
A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated
Follmann D, Fintzi J, Fay MP, et al.
View
Apr 7, 2021
Publication
Collaborative
New England Journal of Medicine
COVID-19, Matrix-M® adjuvant
Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351
Shen X, Tang H, Pajon R, et al
View
Jan 25, 2021
Clinical trial protocol
COVID-19
Current Protocol for Phase 2b Clinical Trial of NVX-CoV2373 in South Africa
View/Download
Jan 14, 2021
Publication
Novavax led
Nature Communications
COVID-19
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
Tian, Jing-Hui, Patel, Nita , Haupt, Robert , et al.
View
Jan 11, 2021
Publication
Novavax included/third party collaborative
Frontiers in Immunology
Malaria, Matrix-M® adjuvant
A Reproducible and Scalable Process for Manufacturing a Pfs48/45 Based Plasmodium falciparum Transmission-Blocking Vaccine
Sing, Susheel K., Plieskatt, ordan, Chourasia, Bishwanath K., et al.
View